Trading symbol: CST
Outstanding shares: 50,261,136
Dr. Versteeg brings significant depth of expertise in carbon capture
systems design and engineering to further support scale up and
optimization of CO2 Solution's patented technology platform
QUEBEC CITY, April 14 /CNW Telbec/ - CO2 Solution Inc. ("CO2 Solution" or
the "Company") announced today that Dr. Geert Versteeg has joined its
Scientific Advisory Board (SAB). Dr. Versteeg brings over 25 years of
professional experience in applied scientific research, including significant
expertise in CO2 capture processes which will be a valuable asset to the
Company in its efforts to scale up and optimize its enzymatic carbon capture
technology for commercial application.
Dr. Versteeg is Director and Co-founder of Procede Group BV ("Procede"),
a leading developer of custom processes requiring advanced
chemical-engineering knowledge, based in The Netherlands. Procede, a spin-off
of Twente University of Technology ("Twente"), employs a research, development
and design staff of 30 engineers and other scientific personnel and has
performed work for numerous organizations in the oil and gas industry
including Shell, Exxon-Mobil and The Dow Chemical Company.
Dr. Versteeg is also Professor and chairholder of Multiphase Reactions at
the State University, Groningen in The Netherlands and was previously
Professor and chairholder of Process Development and Design at Twente. Over
the course of his career, he has co-authored over 200 publications on the
subject of CO2 capture and acid gas treating.
On joining CO2 Solution, Dr. Versteeg remarked "I am very pleased to be
contributing to the development of CO2 Solution's unique technology, which I
firmly believe has the potential to make a significant dent in the cost of
carbon capture across a range of solvent based absorption systems. This type
of innovation will be critical to making CO2 capture widely viable for large
Commenting on the appointment, Glenn Kelly, President & CEO remarked "We
are delighted to have access to Geert's vast knowledge and expertise in gas
treating and believe that his insights will be very valuable to the
commercialization of our technology. We welcome him on board."
About CO2 Solution
CO2 Solution Inc. has developed a proprietary bio-technological platform
for the efficient capture of carbon dioxide (CO2), the most important
greenhouse gas (GHG), from power plants and other large stationary sources of
emissions. The Company's technology platform exploits the natural power of a
bio-catalyst (enzyme), carbonic anhydrase, which functions within humans and
other mammals to manage CO2 during respiration. CO2 Solution has successfully
adapted the enzyme to function within an industrial environment, and thus has
taken advantage of a biomimetic approach to CO2 capture based on millions of
years of evolution. The Company is commercializing its technology for coal
fired power generation, the oil sands and other CO2-intensive industries where
a low-cost capture solution is key to meeting climate change legislation in a
cost effective manner.
CO2 Solution's technology platform is protected by several North American
and European patents, including the use of immobilized carbonic anhydrase for
CO2 capture and release in a packed column system. News releases and
additional information can be found at www.co2solution.com
The TSX Venture Exchange has neither approved nor disapproved the
information contained herein and accepts no responsibility for it.
For further information:
For further information: Annie Chiasson, Director, Corporate Affairs,
(418) 842-3456, firstname.lastname@example.org, www.co2solution.com; Source:
CO2 Solution Inc.